- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketMarket MoversStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare Tata India Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.11 | 1.93 |
NAV | ₹29.90 | ₹426.54 |
Fund Started | 04 Dec 2015 | 04 Jun 1999 |
Fund Size | ₹1231.67 Cr | ₹3689.28 Cr |
Exit Load | Exit load of 0.25% if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.11
1.93
NAV
₹29.90
₹426.54
Fund Started
04 Dec 2015
04 Jun 1999
Fund Size
₹1231.67 Cr
₹3689.28 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 13.65% | 19.31% |
3 Year | 24.87% | 29.09% |
5 Year | 21.50% | 24.17% |
1 Year
13.65%
19.31%
3 Year
24.87%
29.09%
5 Year
21.50%
24.17%
Holding Analysis
Equity | 90.83% | 96.09% |
Cash | 9.17% | 3.83% |
Equity
90.83%
96.09%
Cash
9.17%
3.83%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.64% |
Apollo Hospitals Enterprise Ltd. | 6.22% |
Cipla Ltd. | 5.83% |
Aurobindo Pharma Ltd. | 5.73% |
Divi's Laboratories Ltd. | 5.63% |
Fortis Healthcare Ltd. | 4.90% |
Lupin Ltd. | 4.82% |
Aster DM Healthcare Ltd. | 4.35% |
Wockhardt Ltd. | 3.27% |
Dr. Reddy's Laboratories Ltd. | 3.16% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.73% |
Divi's Laboratories Ltd. | 7.39% |
Max Healthcare Institute Ltd. | 6.40% |
Lonza Group Ag | 4.81% |
Cipla Ltd. | 4.77% |
Lupin Ltd. | 4.46% |
Mankind Pharma Ltd. | 3.75% |
Krishna Institute of Medical Sciences Ltd | 3.34% |
Fortis Healthcare Ltd. | 3.22% |
Acutaas Chemicals Ltd. | 3.19% |
Fund Manager
Name | Meeta Shetty | Tanmaya Desai |
Start Date | 09 Nov 2018 | 27 Jun 2011 |
Name
Meeta Shetty
Tanmaya Desai
Start Date
09 Nov 2018
27 Jun 2011
About Fund
Description | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 04 Dec 2015 | 04 Jun 1999 |
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
04 Dec 2015
04 Jun 1999